Clear up the muddle My advice to anyone.
Go to Onc web site & read the investor presentation.
that is why it is there, in plain clear , concise terms.
First , not one, but two biomarkers have been identified.
both Goblet & Bracelet have been modified to prove the acquired data, with other cancer types.
Secoond.
Pfizer has a 90 day first right of refusal on the Bracelet data. That is in writing & was fully discussed when bracelet was inked.
The Aware-1, trial and results a bit more complicated. There was no formal lockdown of data, other than to protect Roche, they have say in what can be published.
Car-t, the second most recent discovery. That direction is in black & white plain English. They are looking to find a partner who can further the development of Pela as a CAR-t , enhancement.
The most recent discovery, was done third party. That being leukaemia.Pela demonstrated positive results.
further trials are being planned.
That NR came ou5 just before Christmas & is not yet on the Onc web site...too new.
They have 4-5 , studies underway, with news/ results eminently ....meaning , some sooner than others.
my guess lots between Early Jan & late March.